Filing Flows › Equillium (EQ) › Who owns the stock
Who owns Equillium (EQ) stock
61 funds reported Equillium (EQ) shares in their latest 13F filings, worth $151M in all. The largest holder is Jupiter Topco LLC ($20.7M). Last quarter 33 funds added to their stakes and 21 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Jupiter Topco LLC | 6,494,571 | $20.7M | base | 2026-06-30 |
| Decheng Capital LLC | 4,447,308 | $14.2M | unchanged | 2026-06-30 |
| Affinity Asset Advisors, LLC | 4,100,000 | $13.1M | increase | 2026-06-30 |
| Janus Henderson Group | 6,494,571 | $13.0M | increase | 2026-03-31 |
| ADAR1 Capital Management, LLC | 3,758,569 | $12.0M | increase | 2026-06-30 |
| abrdn | 3,631,659 | $11.6M | increase | 2026-06-30 |
| Woodline Partners LP | 3,500,901 | $11.2M | unchanged | 2026-06-30 |
| RA Capital Management, L.P. | 3,096,336 | $9.9M | unchanged | 2026-06-30 |
| Stempoint Capital LP | 2,016,607 | $6.5M | new | 2026-06-30 |
| Vanguard Capital Management LLC | 1,822,812 | $5.8M | increase | 2026-06-30 |
| Eversept Partners, LP | 1,520,824 | $4.9M | increase | 2026-06-30 |
| Adage Capital Partners GP, L.L.C. | 1,390,253 | $4.4M | decrease | 2026-06-30 |
| Vanguard Group | 1,920,423 | $3.0M | increase | 2025-12-31 |
| Takeda Pharmaceutical | 1,824,977 | $2.6M | unchanged | 2025-09-30 |
| Renaissance Technologies LLC | 637,617 | $2.0M | decrease | 2026-06-30 |
Equillium's latest quarter
Equillium, Q4 2024: revenue $4.4M (-52% year over year), operating margin -107.0%, net loss $5.8M, operating cash flow −$3.3M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most EQ stock?
By the latest 13F filings: Jupiter Topco LLC ($20.7M); Decheng Capital LLC ($14.2M); Affinity Asset Advisors, LLC ($13.1M); Janus Henderson Group ($13.0M); ADAR1 Capital Management, LLC ($12.0M).
What is the short interest in EQ?
5,655,364 shares were sold short at the 2026-10-15 settlement, 2.06% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.